oricar-017
Not Tagged
['car-t', 'mmsm', 'polaris']
the phase 1, open-label, single-arm polaris study demonstrated favorable safety and robust efficacy for oricar-017, an autologous gprc5d-directed car-t cell therapy. #asco22 #mmsm 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.